Riskpilot← Back to searchSign inGet full accessVENNESLA LEGESENTER AS
ASActiveOrg 913442148Sentrumsvegen 41, 4700 VenneslaGeneral medical practice activities · NACE 8621Est. 201428 employees
Revenue 2024
NOK 22,2M
+11% vs 2023
EBITDA margin
1.7%
+1182% vs 2023
Equity ratio
44.3%
Financial strength
Net profit 2024
NOK 67K
+125% vs 2023
| Revenue | NOK 22,2M | +11% |
| EBITDA | NOK 383K | +1182% |
| Net profit | NOK 67K | +125% |
| Total assets | NOK 4,8M | +0% |
| Equity | NOK 2,1M | +6% |
| Employees | 28 | — |
Legal name
VENNESLA LEGESENTER AS
Org number
913442148
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
29. mars 2014
Share capital
NOK 1 020 000
Employees
28 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter samt alt hva dermed står i forbindelse, herunder gjennom aksjetegning eller på annen måte å delta i andre selskaper eller foretak.
Address
Sentrumsvegen 41, 4700 Vennesla
Phone
+4738150150
Email
post@venneslalegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 624 | 21 026 | 18 178 | 19 930 | 22 194 |
| Staff expenses | −8 314 | −13 128 | −11 493 | −12 893 | −13 586 |
| EBITDA | 126 | 2 264 | −1 | −35 | 383 |
| Depreciation & amort. | −129 | −216 | −189 | −432 | −326 |
| EBIT | −3 | 2 048 | −190 | −468 | 58 |
| Net financials | 3 | 2 | 1 | 155 | 10 |
| Profit before tax | −0 | 2 050 | −190 | −313 | 67 |
| Tax | 0 | 451 | −41 | −42 | −0 |
| Net profit | −0 | 1 599 | −149 | −271 | 67 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 397 | 5 619 | 4 777 | 4 779 | 4 761 |
| Equity | 825 | 2 282 | 2 193 | 1 982 | 2 110 |
| Long-term debt | 0 | 83 | 42 | 0 | 0 |
| Short-term debt | 2 572 | 3 255 | 2 542 | 2 797 | 2 651 |
| Total debt | 2 572 | 3 338 | 2 584 | 2 797 | 2 651 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20202024
Equity ratio
44.3%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
4.66×
This company
1.12×
Market median
+316% vs market
20202024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IL Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2023 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 6.25% | 6.25% | 2024 | |
| Individual | 3.33% | 3.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VENNESLA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inghild Lund Aamli | Chief Executive Officer | 0 companies |
| Stein Vabo | Chairman | 0 companies |